U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506395) titled 'Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder' on March 18.
Brief Summary: This study is a community-informed, pragmatic, open-label, phase 1 clinical trial of group-format psilocybin-assisted therapy (GPAT) for individuals with post-traumatic stress disorder (PTSD). The primary objectives of this phase 1 study are to assess the safety and feasibility of (GPAT) for individuals with (PTSD) and to evaluate preliminary effects on PTSD severity.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
PTSD
Intervention:
DRUG: Psilocybin
Two group-format dosing sessions, scheduled 4 weeks apart, will b...